Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations

IntroductionThis phase I study explored the immunogenicity and reactogenicity of accelerated, Q7 fractional, intradermal vaccination regimens for COVID-19.MethodsParticipants (n = 60) aged 18-60 years, naïve to SARS-CoV-2 infection or vaccination, were randomly allocated into one of four homologous...

Full description

Bibliographic Details
Main Authors: Suvimol Niyomnaitham, Suparat Atakulreka, Patimaporn Wongprompitak, Katherine Kradangna Copeland, Zheng Quan Toh, Paul V. Licciardi, Kanjana Srisutthisamphan, Laddawan Jansarikit, Kulkanya Chokephaibulkit
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
fractional dose
intradermal
accelerated regimen
COVID-19 vaccination
immunogenicity
heterologous regimen
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1080791/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1080791/full

Similar Items